Ownership Action Don’t Lie: Institutional Investor’s Anti-Steris Corp (NYSE:STE) Sentiment In Q2 2016

November 30, 2016 - By Vivian Park   ·   0 Comments

Ownership Action Don't Lie: Institutional Investor's Anti Steris Corp (NYSE:STE) Sentiment In  Q2 2016

Sentiment for Steris Corp (NYSE:STE)

Steris Corp (NYSE:STE) institutional sentiment decreased to 0.45 in 2016 Q2. Its down -1.15, from 1.6 in 2016Q1. The ratio dived, as 8 hedge funds increased or opened new holdings, while 5 cut down and sold their equity positions in Steris Corp. The hedge funds in our partner’s database now own: 350,212 shares, up from 287,671 shares in 2016Q1. Also, the number of hedge funds holding Steris Corp in their top 10 holdings decreased from 1 to 0 for a decrease of 1. Sold All: 0 Reduced: 5 Increased: 2 New Position: 6.

The stock increased 0.03% or $0.02 during the last trading session, hitting $66.89. STERIS plc Ordinary Shares (NYSE:STE) has declined 7.62% since April 27, 2016 and is downtrending. It has underperformed by 12.85% the S&P500.

Analysts await STERIS plc Ordinary Shares (NYSE:STE) to report earnings on February, 14. They expect $1.04 earnings per share, up 6.12% or $0.06 from last year’s $0.98 per share. STE’s profit will be $88.62M for 16.08 P/E if the $1.04 EPS becomes a reality. After $0.89 actual earnings per share reported by STERIS plc Ordinary Shares for the previous quarter, Wall Street now forecasts 16.85% EPS growth.

According to Zacks Investment Research, “Steris Plc provide infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial and governmental customers. The Company’s operating segments consists of Healthcare, Life Sciences and STERIS Isomedix Services. Healthcare segment manufactures and sells capital equipment, accessory, consumables, information support and service solutions to healthcare providers, including acute care hospitals and surgery and gastrointestinal centers. Life Sciences segment manufactures and sells a range of capital equipment, formulated cleaning chemistries and service solutions to pharmaceutical companies and private and public research facilities. Isomedix segment sells an array of contract processing services as well as laboratory testing services. Steris Plc, formerly known as STERIS Corporation, is headquartered in Leicester, United Kingdom.”

West Coast Financial Llc holds 2.07% of its portfolio in STERIS plc Ordinary Shares for 83,293 shares. Lmr Partners Llp owns 86,749 shares or 0.92% of their US portfolio. Moreover, 12Th Street Asset Management Company Llc has 0.7% invested in the company for 25,760 shares. The Colorado-based Ghp Investment Advisors Inc. has invested 0.41% in the stock. Bragg Financial Advisors Inc, a North Carolina-based fund reported 17,137 shares.#img1#

STERIS plc Ordinary Shares (NYSE:STE) Ratings Coverage

Ratings analysis reveals 100% of Steris’s analysts are positive. Out of 2 Wall Street analysts rating Steris, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $82 while the high is $84. The stock’s average target of $83 is 24.08% above today’s ($66.89) share price. STE was included in 3 notes of analysts from November 2, 2015. Northcoast upgraded the stock to “Buy” rating in Friday, June 3 report.

More important recent STERIS plc Ordinary Shares (NYSE:STE) news were published by: Equitiesfocus.com which released: “STERIS Corporation (NYSE:STE) PEG Ratio At 1.68” on November 25, 2016, also Equitiesfocus.com published article titled: “STERIS Corporation (NYSE:STE) 200-Day MA At $70.05”, Equitiesfocus.com published: “STERIS Corporation (NYSE:STE) Short-Term Price Target At $85.83” on November 16, 2016. More interesting news about STERIS plc Ordinary Shares (NYSE:STE) was released by: Investorplace.com and their article: “5 Dividend Stocks Increasing Payouts – MO INTU STE MLM MGEE” with publication date: August 29, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Vivian Park

Tags: , ,

Readers Comments (0)

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News